Site Management & Patient Recruitment
InquiryIn the current clinical development landscape, nearly 80% of trials fail to meet original enrollment timelines, often resulting in significant financial loss and delayed market entry.
Strategic Site Management & Patient Recruitment Excellence
Protheragen addresses these systemic inefficiencies through a sophisticated integration of site management organization (SMO) services and data-driven patient recruitment. By bridging the gap between complex protocols and frontline clinical execution, we transform the site-patient dynamic from a transactional hurdle into a strategic asset. Our approach prioritizes site sustainability and patient-centric engagement, ensuring that clinical milestones are met with precision, transparency, and high-quality data integrity.
Core Technologies
Protheragen utilizes a proprietary technological stack designed to eliminate the friction points common in traditional trial management. By integrating real-world data with predictive analytics, we provide sponsors with unparalleled visibility into site performance and patient availability.
- Predictive Enrollment Modeling (PEM)
This engine utilizes historical site performance metadata and regional epidemiology to forecast recruitment trajectories. By analyzing over 50 variables per site, we achieve enrollment accuracy rates of up to 95% against initial projections.
- Protheragen Connect Platform
A centralized eClinical ecosystem that acts as a single source of truth. It integrates real-world data (RWD) with electronic health records (EHR) to identify eligible patient populations and track screening milestones in real-time.
- AI-Driven Patient Identification
Our system employs natural language processing (NLP) to scan unstructured physician notes and pathology reports. This technology uncovers "hidden" candidates who meet complex inclusion criteria but might be overlooked during manual database searches.
- Site-Feasibility Algorithms
Beyond simple surveys, our algorithms assess a site's actual capacity by cross-referencing its current study load, staffing levels, and past startup timelines. This ensures we only activate sites that are truly "trial-ready."
- Digital Patient Engagement Tools
We deploy automated, patient-facing interfaces that provide study education, pre-screening questionnaires, and appointment reminders. This reduces the administrative burden on site staff while keeping participants actively engaged.
Inquire Now to Learn More About Protheragen Connect.
Solution Scope
Protheragen provides a comprehensive suite of site-level support services designed to mitigate the administrative burden on clinical investigators.
We provide highly trained on-site coordinators who manage the patient journey. This includes meticulous scheduling, informed consent processing, and longitudinal follow-up to minimize "lost-to-follow-up" rates.
Our team oversees the integrity of biological samples, managing cold-chain logistics and processing. Simultaneously, we maintain the trial master file (TMF) and investigator site file (ISF) to ensure audit readiness at all times.
We operate a 24/7 centralized medical call center staffed by clinical professionals. This service handles initial patient inquiries, preliminary screening, and the immediate documentation and reporting of adverse events (AEs) and serious adverse events (SAEs) to the sponsor and regulatory bodies.
Workflow
Our service process is structured to provide end-to-end oversight, ensuring no detail is overlooked from study startup to close-out.
Fields of Application
Our site management and recruitment expertise spans a wide array of complex therapeutic landscapes:
- Oncology
We navigate the intersection of metabolic health and cancer by managing stringent inclusion criteria and complex biopsy requirements. Our team ensures that participants with comorbid obesity are meticulously screened to provide high-quality, biomarker-driven data for immuno-oncology research.
- Rare Disease
Implementing specialized "concierge" recruitment for ultra-orphan metabolic indications, we provide high-touch support for small patient populations. We focus on removing participation barriers, ensuring that even the rarest genetic obesity disorders are represented by highly engaged study cohorts.
- Neurology
Obesity research often overlaps with CNS disorders. We manage long-term follow-up and caregiver engagement to ensure compliance in trials studying the gut-brain axis, maintaining high retention rates across complex, multi-year neurological and weight-management monitoring periods.
- Cardiology
Our infrastructure supports high-volume recruitment for large-scale cardiovascular outcomes trials (CVOTs). We excel in sourcing obese subjects with specific cardiac risk profiles, ensuring that your study meets the massive enrollment targets required for statistically significant safety data.
- Infectious Disease
We provide rapid site activation and enrollment for metabolic subjects, who are often a high-risk population for emergent diseases. Our ability to mobilize quickly ensures that vaccine and antiviral trials capture the necessary data on efficacy across diverse BMI ranges.
Advantages
Partnering with Protheragen provides sponsors with a competitive edge characterized by speed, quality, and reliability.
Reduced Enrollment Timelines
Our data-led recruitment strategies consistently outperform industry averages, frequently shortening enrollment periods by 20-30%.
Enhanced Data Quality
By placing Protheragen-trained coordinators at the site level, we significantly reduce data entry errors and query response times, leading to cleaner databases at the time of lock.
High Patient Retention
Our "patient-first" engagement model focuses on reducing the burden of participation, resulting in retention rates exceeding 90% across various therapeutic areas.
Scalable Infrastructure
Whether managing a single-site Phase I trial or a global Phase III program, our infrastructure scales seamlessly to meet project demands.
Inquire Now to Optimize Your Site Performance and Recruitment Strategy.
Customer Review
Overcoming Enrollment Stagnation in Complex Phase II Oncology
"Working with Protheragen fundamentally changed our recruitment trajectory. We were struggling with a complex Phase II oncology trial where enrollment had plateaued. Their team embedded a site coordinator who cleared the administrative backlog and implemented a targeted referral program. Within three months, we were back on schedule. We plan to utilize Protheragen for our entire Phase III program."
Dr. S.V., Global Pharmaceutical Lead
Real-Time Data Transparency and Proactive Bottleneck Resolution
"The transparency Protheragen provides is unmatched. Their dashboard allowed us to see real-time screening metrics across all twenty sites, which helped us identify and fix a screening bottleneck in week four rather than week twenty. Their site management expertise saved us both time and significant capital."
Dr. J.E., Director of Patient Advocacy
Frequently Asked Questions
-
How does Protheragen identify sites that won't "under-enroll"?
We use validated historical performance data and current site workload analysis rather than relying solely on investigator-provided estimates.
-
Can you support decentralized or hybrid trial models?
Yes, our technologies facilitate remote monitoring and home-health nursing integration to reach patients outside traditional hub areas.
-
What is your approach to patient diversity?
We utilize localized community outreach and culturally sensitive materials to ensure trial populations reflect the real-world patient demographic.
-
How do you handle site staff turnover?
Our flexible staffing model allows us to deploy Protheragen coordinators immediately to fill gaps, ensuring study continuity.
-
What measures are in place for data security?
Our platforms are fully HIPAA and GDPR compliant, utilizing advanced encryption and multi-factor authentication.
-
How does your recruitment strategy differ for rare diseases?
We pivot from broad digital advertising to targeted patient advocacy group partnerships and global referral networks.
-
Do you assist with budget and contract negotiations?
Yes, we act as a liaison to standardize and accelerate the financial onboarding of sites.
-
What is the typical lead time for site activation?
While protocol-dependent, our streamlined processes often reduce startup times by 4-6 weeks compared to standard CRO models.
-
How do you ensure GCP compliance at the site level?
Through continuous internal audits, regular training updates, and real-time oversight of the site's regulatory binders.
Contact Us
Protheragen provides a sophisticated, technology-driven approach to site management & patient recruitment. By combining on-site personnel support with advanced predictive analytics, we ensure that clinical trials are executed efficiently, ethically, and on schedule. Our commitment to both site success and patient experience makes us the preferred partner for sponsors seeking to de-risk their clinical development timelines.
Contact Protheragen for More Information and to Discuss Your Project
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.